Skip to content
OpenCapital
Get started

Opko Health OPK Net investment gains (losses)

Net investment gains (losses) at other companies

Precigen logo
PrecigenPGEN
$0+100%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$22.58M+1,321%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+11.5%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0×0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDerivativeInstrumentsNetPretax.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's net investment gains (losses).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's net investment gains (losses)?
Opko Health (OPK) reported net investment gains (losses) of -$298K in Q1 2026.
How has Opko Health's net investment gains (losses) changed year-over-year?
Opko Health's net investment gains (losses) decreased by 9.2% year-over-year, from -$273K to -$298K.
What is the long-term trend for Opko Health's net investment gains (losses)?
Over 3 years (2021 to 2025), Opko Health's net investment gains (losses) has grown at a -20.3% compound annual growth rate (CAGR), from $847K to -$429K.
What does net investment gains (losses) mean?
Net realized and unrealized gains and losses on the company's investment portfolio, including equity securities, debt securities, and alternative investments.